Abstract Breast cancer remains one of the most prevalent malignancies among women and is the leading cause of morbidity and mortality. This study was designed to develop and statistically optimized co-loaded tamoxifen (TMX) and letrozole (LTZ) nanostructured lipid carrier coated with hyaluronic acid (HA-TMX-LTZ-NLCs) for synergistic activity towards breast cancer.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile